Back
Day Range
$26.64
$27.19
52-Week Range
$20.92
$27.94
Volume
29,576,037
50D / 200D Avg
$26.63
/
$25.30
Prev Close
$26.97
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 19.6 | 0.4 |
| P/B | 1.8 | 2.9 |
| ROE % | 8.9 | 3.8 |
| Net Margin % | 12.4 | 3.9 |
| Rev Growth 5Y % | -6.3 | 10.0 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$27.50
+2.7%
Low: $24.00
High: $35.00
Forward P/E
9.1
Forward EPS
$2.96
EPS Growth (est.)
+0.0%
Est. Revenue
61 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.23
$2.15 – $2.31
|
52 B | 6 |
| FY2029 |
$2.19
$2.11 – $2.27
|
52 B | 6 |
| FY2028 |
$2.45
$1.61 – $2.91
|
55 B | 8 |
Key Takeaways
Revenue declined -6.33% annually over 5 years
Generating 9.08B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.68%
Cash machine — converts 116.81% of earnings into free cash flow
Capital efficient — spends only 4.20% of revenue on capex
Growth
Revenue Growth (5Y)
-6.33%
Revenue (1Y)-1.65%
Earnings (1Y)-3.12%
FCF Growth (3Y)37.61%
Quality
Return on Equity
8.90%
ROIC7.52%
Net Margin12.42%
Op. Margin24.67%
Safety
Debt / Equity
0.78
Current Ratio1.16
Interest Coverage5.78
Valuation
P/E Ratio
19.60
P/B Ratio1.76
EV/EBITDA14.16
Dividend Yield0.07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.65% | Revenue Growth (3Y) | 2.51% |
| Earnings Growth (1Y) | -3.12% | Earnings Growth (3Y) | 90.86% |
| Revenue Growth (5Y) | -6.33% | Earnings Growth (5Y) | -23.04% |
| Profitability | |||
| Revenue (TTM) | 62.58B | Net Income (TTM) | 7.77B |
| ROE | 8.90% | ROA | 3.73% |
| Gross Margin | 70.33% | Operating Margin | 24.67% |
| Net Margin | 12.42% | Free Cash Flow (TTM) | 9.08B |
| ROIC | 7.52% | FCF Growth (3Y) | 37.61% |
| Safety | |||
| Debt / Equity | 0.78 | Current Ratio | 1.16 |
| Interest Coverage | 5.78 | Dividend Yield | 0.07% |
| Valuation | |||
| P/E Ratio | 19.60 | P/B Ratio | 1.76 |
| P/S Ratio | 2.43 | PEG Ratio | -4.31 |
| EV/EBITDA | 14.16 | Dividend Yield | 0.07% |
| Market Cap | 152.28B | Enterprise Value | 218.55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62.58B | 63.63B | 59.55B | 100.33B | 81.29B |
| Net Income | 7.77B | 8.02B | 2.13B | 31.37B | 22.15B |
| EPS (Diluted) | 1.36 | 1.41 | 0.37 | 5.47 | 3.88 |
| Gross Profit | 44.01B | 41.85B | 30.34B | 62.09B | 46.88B |
| Operating Income | 15.44B | 16.48B | 5.29B | 37.55B | 20.79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 208.16B | 213.40B | 226.50B | 197.21B | 181.48B |
| Total Liabilities | 121.39B | 124.90B | 137.21B | 101.29B | 104.01B |
| Shareholders' Equity | 86.48B | 88.20B | 89.01B | 95.66B | 77.20B |
| Total Debt | 67.42B | 66.99B | 70.85B | 34.86B | 37.00B |
| Cash & Equivalents | 1.14B | 1.04B | 2.85B | 416.00M | 1.94B |
| Current Assets | 42.90B | 50.36B | 43.33B | 51.26B | 59.69B |
| Current Liabilities | 36.98B | 43.00B | 47.79B | 42.14B | 42.67B |